Multi-pathogen infections and Alzheimer's disease

Area of Science:

• Neuroscience
• Infectious Diseases
• Pathology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder linked to amyloid-beta and tau pathology.
• Current AD treatments are not disease-modifying, and many clinical trials have failed.
• The amyloid-beta peptide's antimicrobial function suggests infection may initiate AD.

Purpose of the Study:

• To review the potential role of multi-pathogen infections in Alzheimer's disease etiology.
• To explore how co-existing pathogens and biofilms might contribute to AD pathogenesis.
• To propose novel diagnostic and therapeutic strategies based on a multi-pathogen infection model.

Main Methods:

• Literature review focusing on infectious agents implicated in Alzheimer's disease.
• Analysis of the link between microbial infections, neuroinflammation, and neurodegeneration in AD.
• Synthesis of evidence supporting a multi-pathogen hypothesis for AD.

Main Results:

• Alzheimer's patients exhibit increased susceptibility to infections due to compromised blood-brain barrier and immune function.
• Chronic neuroinflammation and neurodegeneration can result from various microbial infections (viral, bacterial, fungal, parasitic).
• Herpesviruses and periodontal bacteria are frequently associated with AD, but multi-pathogen involvement is likely.

Conclusions:

• Recognizing the potential for multiple pathogens and biofilms in AD etiology is crucial.
• Simultaneous diagnostic testing for major pathogens could improve detection rates.
• Developing multi-antimicrobial treatments (antiviral, antibacterial, antifungal, anti-biofilm) may offer new therapeutic avenues for Alzheimer's disease.